Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Knockdown of CDK6 enhances glioma sensitivity to chemotherapy.

Li B, He H, Tao BB, Zhao ZY, Hu GH, Luo C, Chen JX, Ding XH, Sheng P, Dong Y, Zhang L, Lu YC.

Oncol Rep. 2012 Sep;28(3):909-14. doi: 10.3892/or.2012.1884. Epub 2012 Jun 25.

PMID:
22736304
2.
3.

Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.

Chai KM, Wang CY, Liaw HJ, Fang KM, Yang CS, Tzeng SF.

Oncotarget. 2014 Nov 15;5(21):10901-15.

4.

Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.

Wang Q, Qian J, Wang J, Luo C, Chen J, Hu G, Lu Y.

J Neurooncol. 2013 Mar;112(1):73-82. doi: 10.1007/s11060-013-1045-2. Epub 2013 Jan 6.

PMID:
23292182
5.

Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts.

Gupta SK, Mladek AC, Carlson BL, Boakye-Agyeman F, Bakken KK, Kizilbash SH, Schroeder MA, Reid J, Sarkaria JN.

Clin Cancer Res. 2014 Jul 15;20(14):3730-41. doi: 10.1158/1078-0432.CCR-13-3446. Epub 2014 May 16.

6.

Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.

Lan J, Xue Y, Chen H, Zhao S, Wu Z, Fang J, Han C, Lou M.

FEBS Lett. 2014 Sep 17;588(18):3333-9. doi: 10.1016/j.febslet.2014.07.021. Epub 2014 Jul 29.

7.

Characterization of a side population of astrocytoma cells in response to temozolomide.

Chua C, Zaiden N, Chong KH, See SJ, Wong MC, Ang BT, Tang C.

J Neurosurg. 2008 Nov;109(5):856-66. doi: 10.3171/JNS/2008/109/11/0856.

PMID:
18976075
8.

Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.

Pan SJ, Wu YB, Cai S, Pan YX, Liu W, Bian LG, Sun B, Sun QF.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):476-82. doi: 10.1016/j.bbrc.2015.01.128. Epub 2015 Feb 11.

PMID:
25680464
9.

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.

Ulasov I, Thaci B, Sarvaiya P, Yi R, Guo D, Auffinger B, Pytel P, Zhang L, Kim CK, Borovjagin A, Dey M, Han Y, Baryshnikov AY, Lesniak MS.

Cancer Med. 2013 Aug;2(4):457-67. doi: 10.1002/cam4.104. Epub 2013 Jun 30.

10.

LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.

Qi XC, Xie DJ, Yan QF, Wang YR, Zhu YX, Qian C, Yang SX.

Biochem Biophys Res Commun. 2013 Aug 9;437(4):565-72. doi: 10.1016/j.bbrc.2013.06.116. Epub 2013 Jul 9.

PMID:
23850692
11.

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.

Chen SM, Chen HC, Chen SJ, Huang CY, Chen PY, Wu TW, Feng LY, Tsai HC, Lui TN, Hsueh C, Wei KC.

World J Surg Oncol. 2013 Apr 17;11:87. doi: 10.1186/1477-7819-11-87.

12.

Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.

Gong A, Ge N, Yao W, Lu L, Liang H.

Cancer Chemother Pharmacol. 2014 Sep;74(3):531-8. doi: 10.1007/s00280-014-2534-5. Epub 2014 Jul 22.

PMID:
25047724
13.

Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.

Zhou Y, Wang HD, Zhu L, Cong ZX, Li N, Ji XJ, Pan H, Wang JW, Li WC.

Oncol Rep. 2013 Jan;29(1):394-400. doi: 10.3892/or.2012.2115. Epub 2012 Oct 31.

PMID:
23128449
14.

Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.

Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, Day PJ, Lui WM, Fung CF, Leung GK.

Neuro Oncol. 2013 May;15(5):562-77. doi: 10.1093/neuonc/not005. Epub 2013 Feb 26.

15.

Gene expression profiling predicts response to temozolomide in malignant gliomas.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E, Tsumoto K.

Int J Oncol. 2010 Jun;36(6):1367-77.

PMID:
20428759
16.

Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway.

Wang Q, Du J, Xu B, Xu L, Wang X, Liu J, Wang J.

Acta Biochim Biophys Sin (Shanghai). 2016 Jun;48(6):501-8. doi: 10.1093/abbs/gmw035. Epub 2016 May 17.

PMID:
27189511
17.

TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.

Zhuang D, Liu Y, Mao Y, Gao L, Zhang H, Luan S, Huang F, Li Q.

Int J Cancer. 2012 Jan 15;130(2):309-18. doi: 10.1002/ijc.25985. Epub 2011 May 30.

18.

The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents.

Chen CC, Taniguchi T, D'Andrea A.

J Mol Med (Berl). 2007 May;85(5):497-509. Epub 2007 Jan 13.

PMID:
17221219
19.

Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.

Zhou B, Bu G, Zhou Y, Zhao Y, Li W, Li M.

Med Oncol. 2015 Jan;32(1):378. doi: 10.1007/s12032-014-0378-9. Epub 2014 Nov 30.

PMID:
25433945
20.

The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.

Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R.

Neuro Oncol. 2013 Mar;15(3):269-78. doi: 10.1093/neuonc/nos301. Epub 2012 Dec 20.

Supplemental Content

Support Center